Developer docs
API playgroundTry for free, no card

Search company profiles

UK Innovation & Science Seed Fund

Full company profile

uuid0003ogj

Namestring
UK Innovation & Science Seed Fund
Legal namestring
Future Planet Capital (Ventures) Limited
Company typeenum
Private
Founded yearint
2009
Descriptiontext

UK Innovation & Science Seed Fund (UKI2S) is a UK national, impact-first pre-seed and seed venture capital fund investing in early-stage science and technology spinouts. Founded in 2009 as the Rainbow Seed Fund and rebranded in 2018, the fund is managed by Future Planet Capital (Ventures) Limited, an FCA-regulated entity (FRN 148549) headquartered in Manchester with offices in London and Birmingham. UKI2S operates six thematic investment portfolios — Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space — targeting companies spun out of UK universities and publicly-funded research establishments such as Harwell, Sci-Tech Daresbury, Babraham, the National Physical Laboratory, and UKAEA.

UKI2S's underlying "product" is structured equity capital combined with hands-on portfolio support: leadership coaching, board formation, executive recruitment, further funding strategy, ESG/DE&I advancement, and network leverage via Future Planet Capital. The fund typically leads or co-leads seed rounds (e.g., Optera, Messium, K3Metrology, Spaceflux) and participates in selected Series A and grant-matched financings. Its portfolio spans space domain awareness, neuromorphic sensing, fusion energy, agri-biotech, AI-driven drug discovery, metrology, geothermal critical mineral recovery, and battery diagnostics.

The fund's revenue model is standard venture capital: management fees on committed and invested capital plus carried interest on exits, with no product or service pricing. As of June 2026 the fund's AUM stood at £150 million following a £33.25m injection from the UK Space Agency, Ministry of Defence and UK Atomic Energy Authority. UKI2S reports £1bn+ of co-investment into its portfolio (£5.90–£25 of private capital per £1 deployed), 70+ companies backed, ~50% of portfolio capital in R&D, and 1,100+ high-value jobs created over its 20-year operating history.

Short descriptiontext

UK Innovation & Science Seed Fund (UKI2S) is a UK national, impact-first pre-seed and seed venture capital fund that backs early-stage deep-tech spinouts from UK publicly-funded research across Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHarwell, United Kingdom
HQ citystring
Harwell
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
early-stage venture capital, deep-tech seed funding, science spinout investment, pre-seed investment fund, technology startup financing
Industry1 code
1Impact Investment & Development Investment Funds
CodeBPADACAOPrimaryYes
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Other Financial Vehicles525990
SIC code1 code
  • Investment Advice6282
Product category
Early-Stage Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeLicensing Royalties
Description

UKI2S generates returns through successful exits of portfolio companies. As a patient capital investor, the fund provides early-stage funding to science-driven startups and aims to deliver both impact and financial returns through equity ownership in portfolio companies.

ukinnovationscienceseedfund.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

UKI2S is a national pre-seed+ venture capital fund that invests equity capital into early-stage UK science and technology spinouts across six thematic portfolios: Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space. In addition to funding, the fund delivers ongoing hands-on support including leadership coaching, board establishment, executive recruitment, follow-on funding strategy, DE&I and ESG advancement, and access to the Future Planet Capital investor network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • £1 billion co-investment into portfolio
+3 more records
Product overview1 text field

UK Innovation & Science Seed Fund (UKI2S) is a national pre-seed+ investment fund with £110m AUM managed by Future Planet Capital. It is not a product company but rather an impact-first investor that provides seed funding and support to early-stage UK spinouts. The fund operates six thematic investment portfolios: Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space. UKI2S supports portfolio companies through leadership coaching, further funding strategy, executive recruitment, network leverage, and ESG/DE&I advancement. The fund has backed 70+ companies, co-invested £1 billion, created 1,100+ high-value jobs, and reports £25 of private investment attracted for every £1 invested.

Product and service6 records
1Defence & Security Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio for UK startups developing technologies to protect citizens and empower defence and security services. Portfolio includes HonuWorx, Oxford Space Systems, Spaceflux, Aquark Technologies, CryogenX, and Silveray.

2Engineering Biology Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio for UK startups applying engineering biology across agriculture, healthcare, and manufacturing. Portfolio includes Cytotrait, Resurrect Bio, Ternary Therapeutics, Synthace, Tropic Biosciences, Ikarovec, NK:IO, Revolver Therapeutics, and others.

3Fusion Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio for UK startups advancing fusion energy and adjacent technologies. Portfolio includes Tokamak Energy, Sention, Fusion Energy Partners, mach42, MuWave, and Wave Photonics.

4Knowledge Assets Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio focused on commercialising intellectual property from the UK public sector, including the National Physical Laboratory. Portfolio includes K3 Metrology, Sona, Spotlight Pathology, HiDRA, and Presymptom Health.

5Partner Innovation Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio for deep-tech spinouts from UK publicly funded research establishments, science campuses, and translational catapult centres. Portfolio includes Adamo Foods, Atheras Analytics, Atelerix, IGS, Vector Photonics, and QDot.

6Space Portfolio
CategoryInvestment Portfolio
Description

Pre-seed and seed equity investment portfolio for UK space startups developing space-based technology and space domain awareness solutions. Portfolio includes Oxford Space Systems, Spaceflux, Optera, and Messium.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UKI2S works closely with the UK Space Agency to back relevant space sector entrepreneurs who seek to deliver on key aspects of the National Space Strategy and UK Space Agency Corporate Plan.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NPL is a key partner providing spinout opportunities and technology commercialisation pathways for measurement and metrology innovations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MoD is both an investor in UKI2S (providing £33.2m injection) and a source of defence and security spinout opportunities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UKRI and its councils (including NERC, MRC, BBSRC) are key partners providing research spinout opportunities across multiple sectors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

DSIT is a key government partner supporting the fund's mission to advance UK science and technology innovation.

6Research Campuses Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner campuses include Harwell Science and Innovation Campus, Sci-Tech Daresbury, Babraham Research Campus, and others providing deal flow and research collaboration opportunities.

ukinnovationscienceseedfund.co.uk
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based early-stage technology investor focused on university spinouts and deep-tech companies from UK research institutions. Directly comparable as a seed/early-stage fund targeting similar UK academic spinout deal flow.

TypeDirect peer
Description

UK regional investor with university-linked funds and EIS-focused early-stage vehicles. Overlaps with UKI2S in backing UK spinouts and knowledge-intensive startups.

TypeRegional player
Description

Regional development agencies that co-invest in Scottish deep-tech and life-science spinouts. Adjacent regional capital provider to the same UK deep-tech ecosystem UKI2S targets.

TypeDirect peer
Description

UK venture and growth investor with VCTs and institutional funds backing early-stage technology and life-science companies. Comparable UK early-stage tech investor with similar sector breadth.

TypeBroad incumbent
Description

One of the largest UK VCs, with a portfolio spanning health, fintech, and deep tech. Broader incumbent that overlaps with UKI2S in early-stage UK technology investing.

TypeDirect peer
Description

UK investment manager focused on early-stage technology companies, with significant overlap in engineering biology, advanced materials, and deep-tech spinouts. Comparable scale and stage.

TypeDirect peer
Description

UK growth investment firm focused on science and technology-enabled businesses in the North of England, anchored by northern universities. Competes with UKI2S for university spinout deals across similar sectors.

TypeDirect peer
Description

Invests in deep-tech and life-science companies from the Cambridge ecosystem. Similar profile to UKI2S as a UK deep-tech specialist fund backing spinouts from leading research universities.

TypeDirect peer
Description

Investment company created to commercialise University of Oxford research. Directly comparable deep-tech spinout investor with multi-vertical coverage of life sciences, health tech, and deep tech.

TypeBroad incumbent
Description

UK government-backed development institution providing venture and growth capital across the UK. Comparable as a public-mandated investor in UK innovation and deep-tech ecosystems, though broader in scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment150 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UK Innovation & Science Seed Fund

Early-Stage Venture Capitalukinnovationscienceseedfund.co.uk

UK Innovation & Science Seed Fund (UKI2S) is a UK national, impact-first pre-seed and seed venture capital fund that backs early-stage deep-tech spinouts from UK publicly-funded research across Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space.

What UK Innovation & Science Seed Fund does

UK Innovation & Science Seed Fund (UKI2S) is a UK national, impact-first pre-seed and seed venture capital fund investing in early-stage science and technology spinouts. Founded in 2009 as the Rainbow Seed Fund and rebranded in 2018, the fund is managed by Future Planet Capital (Ventures) Limited, an FCA-regulated entity (FRN 148549) headquartered in Manchester with offices in London and Birmingham. UKI2S operates six thematic investment portfolios — Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space — targeting companies spun out of UK universities and publicly-funded research establishments such as Harwell, Sci-Tech Daresbury, Babraham, the National Physical Laboratory, and UKAEA.

UKI2S's underlying "product" is structured equity capital combined with hands-on portfolio support: leadership coaching, board formation, executive recruitment, further funding strategy, ESG/DE&I advancement, and network leverage via Future Planet Capital. The fund typically leads or co-leads seed rounds (e.g., Optera, Messium, K3Metrology, Spaceflux) and participates in selected Series A and grant-matched financings. Its portfolio spans space domain awareness, neuromorphic sensing, fusion energy, agri-biotech, AI-driven drug discovery, metrology, geothermal critical mineral recovery, and battery diagnostics.

The fund's revenue model is standard venture capital: management fees on committed and invested capital plus carried interest on exits, with no product or service pricing. As of June 2026 the fund's AUM stood at £150 million following a £33.25m injection from the UK Space Agency, Ministry of Defence and UK Atomic Energy Authority. UKI2S reports £1bn+ of co-investment into its portfolio (£5.90–£25 of private capital per £1 deployed), 70+ companies backed, ~50% of portfolio capital in R&D, and 1,100+ high-value jobs created over its 20-year operating history.

UK Innovation & Science Seed Fund firmographics

Firmographics
Name
UK Innovation & Science Seed Fund
Legal name
Future Planet Capital (Ventures) Limited
Website
https://ukinnovationscienceseedfund.co.uk
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
UK Innovation & Science Seed Fund (UKI2S) is a UK national, impact-first pre-seed and seed venture capital fund that backs early-stage deep-tech spinouts from UK publicly-funded research across Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space.
Ownership category
akta.pro rank

UK Innovation & Science Seed Fund industry classification

Industry
Product category
Early-Stage Venture Capital
NAICS
Other Investment Pools and Funds (5259), Other Financial Vehicles (525990)
SIC
Investment Advice (6282)
akta.pro primary industry
Impact Investment & Development Investment Funds (BPADACAO)

Keywords

  • Early-stage venture capital
  • Deep-tech seed funding
  • Science spinout investment
  • Pre-seed investment fund
  • Technology startup financing

Where UK Innovation & Science Seed Fund is headquartered

Location

Headquarters

HQ city
Harwell
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

UK Innovation & Science Seed Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Fund Management: UKI2S generates returns through successful exits of portfolio companies. As a patient capital investor, the fund provides early-stage funding to science-driven startups and aims to deliver both impact and financial returns through equity ownership in portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

UK Innovation & Science Seed Fund product offering

Product offering

Core offering

UKI2S is a national pre-seed+ venture capital fund that invests equity capital into early-stage UK science and technology spinouts across six thematic portfolios: Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space. In addition to funding, the fund delivers ongoing hands-on support including leadership coaching, board establishment, executive recruitment, follow-on funding strategy, DE&I and ESG advancement, and access to the Future Planet Capital investor network.

Product overview

UK Innovation & Science Seed Fund (UKI2S) is a national pre-seed+ investment fund with £110m AUM managed by Future Planet Capital. It is not a product company but rather an impact-first investor that provides seed funding and support to early-stage UK spinouts. The fund operates six thematic investment portfolios: Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space. UKI2S supports portfolio companies through leadership coaching, further funding strategy, executive recruitment, network leverage, and ESG/DE&I advancement. The fund has backed 70+ companies, co-invested £1 billion, created 1,100+ high-value jobs, and reports £25 of private investment attracted for every £1 invested.

Differentiator

Problem solved

Functional benefit

Products and services

  • Defence & Security Portfolio Pre-seed and seed equity investment portfolio for UK startups developing technologies to protect citizens and empower defence and security services. Portfolio includes HonuWorx, Oxford Space Systems, Spaceflux, Aquark Technologies, CryogenX, and Silveray.
  • Engineering Biology Portfolio Pre-seed and seed equity investment portfolio for UK startups applying engineering biology across agriculture, healthcare, and manufacturing. Portfolio includes Cytotrait, Resurrect Bio, Ternary Therapeutics, Synthace, Tropic Biosciences, Ikarovec, NK:IO, Revolver Therapeutics, and others.
  • Fusion Portfolio Pre-seed and seed equity investment portfolio for UK startups advancing fusion energy and adjacent technologies. Portfolio includes Tokamak Energy, Sention, Fusion Energy Partners, mach42, MuWave, and Wave Photonics.
  • Knowledge Assets Portfolio Pre-seed and seed equity investment portfolio focused on commercialising intellectual property from the UK public sector, including the National Physical Laboratory. Portfolio includes K3 Metrology, Sona, Spotlight Pathology, HiDRA, and Presymptom Health.
  • Partner Innovation Portfolio Pre-seed and seed equity investment portfolio for deep-tech spinouts from UK publicly funded research establishments, science campuses, and translational catapult centres. Portfolio includes Adamo Foods, Atheras Analytics, Atelerix, IGS, Vector Photonics, and QDot.
  • Space Portfolio Pre-seed and seed equity investment portfolio for UK space startups developing space-based technology and space domain awareness solutions. Portfolio includes Oxford Space Systems, Spaceflux, Optera, and Messium.

Quantifiable outcome

  • £1 billion co-investment into portfolio
  • +3 more outcomes

Companies that use UK Innovation & Science Seed Fund

Customer profile

Segments3 records

Ideal customer profiles2 records

UK Innovation & Science Seed Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

UK Innovation & Science Seed Fund partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • UK Space AgencycoreStrategic or Co-development PartnerUKI2S works closely with the UK Space Agency to back relevant space sector entrepreneurs who seek to deliver on key aspects of the National Space Strategy and UK Space Agency Corporate Plan.
  • National Physical LaboratorycoreStrategic or Co-development PartnerNPL is a key partner providing spinout opportunities and technology commercialisation pathways for measurement and metrology innovations.
  • Ministry of DefencecoreStrategic or Co-development PartnerMoD is both an investor in UKI2S (providing £33.2m injection) and a source of defence and security spinout opportunities.
  • UK Research and Innovation (UKRI)coreStrategic or Co-development PartnerUKRI and its councils (including NERC, MRC, BBSRC) are key partners providing research spinout opportunities across multiple sectors.
  • Department for Science, Innovation and TechnologycoreStrategic or Co-development PartnerDSIT is a key government partner supporting the fund's mission to advance UK science and technology innovation.
  • Research Campuses NetworkcoreStrategic or Co-development PartnerPartner campuses include Harwell Science and Innovation Campus, Sci-Tech Daresbury, Babraham Research Campus, and others providing deal flow and research collaboration opportunities.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

UK Innovation & Science Seed Fund competitors and assessment

Company assessment

Direct peers

  • Parkwalk Advisors: UK-based early-stage technology investor focused on university spinouts and deep-tech companies from UK research institutions. Directly comparable as a seed/early-stage fund targeting similar UK academic spinout deal flow.
  • Mercia Asset Management: UK regional investor with university-linked funds and EIS-focused early-stage vehicles. Overlaps with UKI2S in backing UK spinouts and knowledge-intensive startups.
  • Albion Capital: UK venture and growth investor with VCTs and institutional funds backing early-stage technology and life-science companies. Comparable UK early-stage tech investor with similar sector breadth.
  • Foresight Williams Technology: UK investment manager focused on early-stage technology companies, with significant overlap in engineering biology, advanced materials, and deep-tech spinouts. Comparable scale and stage.
  • Northern Gritstone: UK growth investment firm focused on science and technology-enabled businesses in the North of England, anchored by northern universities. Competes with UKI2S for university spinout deals across similar sectors.
  • Cambridge Innovation Capital: Invests in deep-tech and life-science companies from the Cambridge ecosystem. Similar profile to UKI2S as a UK deep-tech specialist fund backing spinouts from leading research universities.
  • Oxford Science Enterprises (OSE): Investment company created to commercialise University of Oxford research. Directly comparable deep-tech spinout investor with multi-vertical coverage of life sciences, health tech, and deep tech.

Regional players

Broad incumbents

  • Octopus Ventures: One of the largest UK VCs, with a portfolio spanning health, fintech, and deep tech. Broader incumbent that overlaps with UKI2S in early-stage UK technology investing.
  • British Business Bank - Future Fund / UK Innovation Finance: UK government-backed development institution providing venture and growth capital across the UK. Comparable as a public-mandated investor in UK innovation and deep-tech ecosystems, though broader in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

UK Innovation & Science Seed Fund social profiles

Digital presence

UK Innovation & Science Seed Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UK Innovation & Science Seed Fund leadership team

Management profile

Number of profiles

Profiles9 records

UK Innovation & Science Seed Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UK Innovation & Science Seed Fund M&A and investment

M&A and investment

M&A

Investments150 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UK Innovation & Science Seed Fund

What does UK Innovation & Science Seed Fund do?

UKI2S is a national pre-seed+ venture capital fund that invests equity capital into early-stage UK science and technology spinouts across six thematic portfolios: Defence & Security, Engineering Biology, Fusion, Knowledge Assets, Partner Innovation, and Space. In addition to funding, the fund delivers ongoing hands-on support including leadership coaching, board establishment, executive recruitment, follow-on funding strategy, DE&I and ESG advancement, and access to the Future Planet Capital investor network.

Is UK Innovation & Science Seed Fund a public or private company?

UK Innovation & Science Seed Fund is a private company. It is classified as state government owned and is currently operating.

When was UK Innovation & Science Seed Fund founded?

UK Innovation & Science Seed Fund was founded in 2009. It employs 11 to 50 people.

Where is UK Innovation & Science Seed Fund based?

UK Innovation & Science Seed Fund is headquartered in Harwell, United Kingdom, in the Europe region.

How does UK Innovation & Science Seed Fund make money?

One revenue line is on record: fund Management.

Who are UK Innovation & Science Seed Fund's main competitors?

Direct peers on record are Parkwalk Advisors, Mercia Asset Management, Albion Capital, Foresight Williams Technology, Northern Gritstone, Cambridge Innovation Capital and Oxford Science Enterprises (OSE). Scottish Enterprise / Highlands and Islands Enterprise (co-investment partners) is listed as a regional player. Broad incumbents are Octopus Ventures and British Business Bank - Future Fund / UK Innovation Finance.

Does UK Innovation & Science Seed Fund have an API?

No public API is recorded for UK Innovation & Science Seed Fund.

What industry is UK Innovation & Science Seed Fund in?

UK Innovation & Science Seed Fund's product category is Early-Stage Venture Capital. Its primary akta.pro industry code is BPADACAO, Impact Investment & Development Investment Funds. Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmagIMS Solutions raises £1.1m led by Midlands Mindforge with SFC CapitalIMS Solutions raised £1.1m in seed funding led by Midlands Mindforge, with SFC Capital participation, to accelerate regulatory certification of its ACCelerate adrenal tumour test. The company also received a £2.1m NIHR award for product development and clinical validation. The funds will support the test and a blood-based stratification test for polyendocrine metabolic ovarian syndrome.MorningstarStandardX Launches With £10M Seed Round to Create the Rare Isotopes Needed to Advance Medical and Fusion InnovationStandardX raised £10M in seed funding led by Vsquared Ventures and East X Ventures to build the world's first isotope refinery. The company will begin pilot production of medical isotopes in 2027, with industrial-scale production from 2029, and has signed agreements with fusion developers for tritium.Tech.euStandardX launches with £10M to expand isotope production for medicine and fusionStandardX raised £10 million in seed funding to develop an accelerator-based isotope refinery for medicine and fusion. The company plans to supply its first isotopes to a medical research partner in 2027, with industrial-scale production from 2029. It also aims to produce tritium for fusion energy.StartupmagKVector raises £3.8m led by Midlands Mindforge and Midlands Engine Investment Fund IIKVector, a University of Birmingham spin-out, raised £3.8m in seed funding led by Midlands Mindforge and Midlands Engine Investment Fund II. The funds will accelerate product development and recruitment for its metamaterial beam-steered antenna, targeting defence and satellite communications. The technology aims to reduce cost, weight, and power consumption of radar and satellite equipment.StartupmagNottingham-based HALO X-ray Technologies closes growth round led by Agilent and UKI2SHALO X-ray Technologies closed a growth round led by Agilent Technologies with participation from UKI2S and MEIF. The funding will complete regulatory approval for its X-ray diffraction system and support production and commercialization for airport and border screening. The company aims to reduce false positives and manual checks.FinSMEsHALO Closes FundingHALO X-ray Technologies, a UK-based X-ray detection firm, raised an undisclosed amount in funding led by Agilent Technologies, with UKI2S and MEIF following. The company will use the funds to expand operations and development efforts. HALO focuses on security screening and analytical instrumentation.MorningstarAgilent Increases Its Investment in HALO X-ray TechnologiesAgilent Technologies led a multimillion-dollar investment round in HALO X-ray Technologies, with UK Innovation Science Seed Fund and Midland Engine Investment Fund participating. The funding will help HALO complete regulatory approval of its X-ray diffraction screening technology and scale up commercial activities.StartupmagSilicon Microgravity raises £6m led by West Hill Capital with UKI2SSilicon Microgravity raised £6m in growth funding led by West Hill Capital with UKI2S participation. The cash will expand UK manufacturing and accelerate commercial deployment of MEMS sensors for defence, space, and dual-use markets. The funding signals investor interest in sovereign sensing and advanced manufacturing.Business LiveBath spin-out developing new cancer treatment raises half a million poundsRevolver Therapeutics, a University of Bath spin-out, raised £572,000 in funding led by QantX. The company will use the money to develop therapeutics for colorectal cancer, having already shown it can stop tumour cells growing in the lab.InsidermediaBath spin-out developing peptide therapeutics raises further £572,000Revolver Therapeutics, a peptide therapeutics spin-out from the University of Bath, has closed a £572,000 funding round led by QantX with participation from the UK Innovation & Science Seed Fund and the University of Bath. The funding will advance the company's Transcription Block Survival platform and support development of peptide treatments targeting transcription factors for colorectal cancer, an area that has been historically difficult to address with conventional drugs. The company highlighted this as a significant vote of confidence in its science and team.